Canadian Sec - Delayed Quote CAD
Britannia Life Sciences Inc. (BLAB.CN)
At close: October 18 at 12:55 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
1,489.6920
2,091.6560
2,008.3740
2,799.4090
-586.5760
Investing Cash Flow
-1,126.9330
-1,440.6870
-3,324.3660
653.9490
-4,913.1160
Financing Cash Flow
-2,035.0500
-1,972.3600
2,155.3570
-2,579.3070
6,202.1230
End Cash Position
760.3400
1,322.5840
2,598.2730
1,631.1270
828.3210
Capital Expenditure
-192.4700
-337.4740
-342.3000
-87.0830
--
Issuance of Debt
--
27.0340
7,979.8420
1,528.0570
6,222.0480
Repayment of Debt
-2,062.0840
-1,999.3940
-5,032.8180
-3,515.5270
-19.1480
Free Cash Flow
1,297.2220
1,754.1820
1,666.0740
2,712.3260
-586.5760
3/31/2021 - 11/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MOOD.CN Doseology Sciences Inc.
0.3000
+87.50%
ACOG.CN Alpha Cognition Inc.
0.6000
+15.38%
MSCL.TO Satellos Bioscience Inc.
0.8000
+17.65%
ACOGF Alpha Cognition Inc.
0.4650
+3.68%
SVA.TO Sernova Corp.
0.2650
0.00%
CDTX Cidara Therapeutics, Inc.
11.26
+0.99%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1450
+3.57%
CKPT Checkpoint Therapeutics, Inc.
3.0100
+1.35%
ARWR Arrowhead Pharmaceuticals, Inc.
21.18
+1.63%
SGMO Sangamo Therapeutics, Inc.
0.9207
-1.60%